Shanyu Chen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Shanyu Chen has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Beifang Niu
Computer Network Information Center, Chinese Academy of Sciences, Beijing, China
1 shared publication - Chuangchuang Dai
Computer Network Information Center, Chinese Academy of Sciences, Beijing 100190, China; University of Chinese Academy of Sciences, Beijing 100190, China
1 shared publication - Dan Zhao
Computer Network Information Center, Chinese Academy of Sciences, Beijing 100190, China; University of Chinese Academy of Sciences, Beijing 100190, China
1 shared publication - Fen Wang
Department of Oncology, Peking University Shenzhen Hospital, Shenzhen, Guangdong, People's Republic of China
1 shared publication - Haidong Zhu
Computer Network Information Center, Chinese Academy of Sciences, Beijing 100190, China; University of Chinese Academy of Sciences, Beijing 100190, China
1 shared publication - Jianhua Xu
Department of Gastrointestinal Surgery, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, China
1 shared publication
Latest Publications
- Open Access
- 1 August 2019
- Published by Oxford University Press (OUP) in Genomics, Proteomics & Bioinformatics
- Vol. 17 (4) , 381-392
How Big Data and High-Performance Computing Drive Brain Science
Brain science accelerates the study of intelligence and behavior, contributes fundamental insights into human cognition, and offers prospective treatments for brain disease. Faced with the challenges posed by imaging technologies and deep learning computational models, big data and high-performance computing (HPC) play essential roles in studying brain function, brain diseases, and large-scale brain models or connectomes. We review the driving forces behind big data and HPC methods applied to brain science, including deep learning, powerful data analysis capabilities, and computational performance solutions, each of which can be used to improve diagnostic accuracy and research output. This work reinforces predictions that big data and HPC will continue to improve brain science by making ultrahigh-performance analysis possible, by improving data standardization and sharing, and by providing new neuromorphic insights.
- 1 August 2019
- Published by Oxford University Press (OUP) in Genomics, Proteomics & Bioinformatics
- Vol. 17 (4) , 381-392
Open AccessHow Big Data and High-Performance Computing Drive Brain Science
Brain science accelerates the study of intelligence and behavior, contributes fundamental insights into human cognition, and offers prospective treatments for brain disease. Faced with the challenges posed by imaging technologies and deep learning computational models, big data and high-performance computing (HPC) play essential roles in studying brain function, brain diseases, and large-scale brain models or connectomes. We review the driving forces behind big data and HPC methods applied to brain science, including deep learning, powerful data analysis capabilities, and computational performance solutions, each of which can be used to improve diagnostic accuracy and research output. This work reinforces predictions that big data and HPC will continue to improve brain science by making ultrahigh-performance analysis possible, by improving data standardization and sharing, and by providing new neuromorphic insights.
- 6 October 2017
- Published by Wiley in International Journal of Rheumatic Diseases
- Vol. 20 (12) , 2053-2061
Association of glucocorticoid receptor gene polymorphisms with systemic lupus erythematosus in a Chinese population
Objectives: To identify the association of glucocorticoid receptor (GR) gene polymorphism with systemic lupus erythematosus (SLE).Methods: A case‐control study was carried out, in which 400 Chinese patients with SLE and 400 normal people were enrolled. DNA was extracted using a genomic DNA extraction kit, and tagged single nucleotide polymorphisms (SNPs) were identified by Haploview (4.0) Project from the Chinese HapMap Project. Eighteen tagged SNPs of the GR gene were genotyped by the Multiplex SNaPshot technique.Results: Two GR gene SNPs were associated with the pathogenesis of SLE: rs6865292 (dominant model: crude odds ratio [OR] = 1.526, 95% CI: 1.151–2.025, P = 0.003; adjusted OR = 1.525, 95% CI: 1.149–2.023, P = 0.004; PBH = 0.036) and rs9324921 (dominant model: crude OR = 1.556, 95% CI: 1.173–2.062, P = 0.002; adjusted OR = 1.553, 95% CI: 1.171–2.060, P = 0.002; PBH = 0.036). The haplotype analysis of GR gene SNPs manifested that the haplotype of ‘CCGGG’ (OR = 2.701, 95% CI: 1.348–5.410, P = 0.004; PBH = 0.036) was a risk factor for the development of SLE. A lower frequency of A‐allele of SNP rs4607376 (P = 0.021; OR = 0.794, 95% CI: 0.652–0.966, PBH = 0.126), higher frequency of C‐allele of SNP rs6865292 (P = 0.019, OR = 1.317, PBH = 0.126) and A‐allele of SNP rs9324921 (P = 0.019, OR = 1.317, PBH = 0.126) may be risk factors for developing SLE. The rs7719514 (recessive model: crude P = 0.044; adjusted P = 0.044, PBH = 0.264), rs7701443 (recessive model: crude P = 0.044, adjusted P = 0.045; PBH = 0.264), rs4607376 (recessive model: crude P = 0.027; adjusted P = 0.026; PBH = 0.264) and haplotype ‘CAGCG’ (P = 0.044; PBH = 0.198) showed marginal association with the pathogenesis of SLE. In the case group, there were no significant differences between non‐lupus nephritis and lupus nephritis. Further, we found that the SNP rs12054797 (F = 3.228, P = 0.041, PBH = 0.342), rs2963156 (F = 3.163, P = 0.043, PBH = 0.342) might be marginally associated with disease activity.Conclusions: The study indicates that GR genetic polymorphisms may play a major role in the pathogenesis and development of SLE.
- 6 October 2017
- Published by Wiley in International Journal of Rheumatic Diseases
- Vol. 20 (12) , 2053-2061
Association of glucocorticoid receptor gene polymorphisms with systemic lupus erythematosus in a Chinese population
Objectives: To identify the association of glucocorticoid receptor (GR) gene polymorphism with systemic lupus erythematosus (SLE).Methods: A case‐control study was carried out, in which 400 Chinese patients with SLE and 400 normal people were enrolled. DNA was extracted using a genomic DNA extraction kit, and tagged single nucleotide polymorphisms (SNPs) were identified by Haploview (4.0) Project from the Chinese HapMap Project. Eighteen tagged SNPs of the GR gene were genotyped by the Multiplex SNaPshot technique.Results: Two GR gene SNPs were associated with the pathogenesis of SLE: rs6865292 (dominant model: crude odds ratio [OR] = 1.526, 95% CI: 1.151–2.025, P = 0.003; adjusted OR = 1.525, 95% CI: 1.149–2.023, P = 0.004; PBH = 0.036) and rs9324921 (dominant model: crude OR = 1.556, 95% CI: 1.173–2.062, P = 0.002; adjusted OR = 1.553, 95% CI: 1.171–2.060, P = 0.002; PBH = 0.036). The haplotype analysis of GR gene SNPs manifested that the haplotype of ‘CCGGG’ (OR = 2.701, 95% CI: 1.348–5.410, P = 0.004; PBH = 0.036) was a risk factor for the development of SLE. A lower frequency of A‐allele of SNP rs4607376 (P = 0.021; OR = 0.794, 95% CI: 0.652–0.966, PBH = 0.126), higher frequency of C‐allele of SNP rs6865292 (P = 0.019, OR = 1.317, PBH = 0.126) and A‐allele of SNP rs9324921 (P = 0.019, OR = 1.317, PBH = 0.126) may be risk factors for developing SLE. The rs7719514 (recessive model: crude P = 0.044; adjusted P = 0.044, PBH = 0.264), rs7701443 (recessive model: crude P = 0.044, adjusted P = 0.045; PBH = 0.264), rs4607376 (recessive model: crude P = 0.027; adjusted P = 0.026; PBH = 0.264) and haplotype ‘CAGCG’ (P = 0.044; PBH = 0.198) showed marginal association with the pathogenesis of SLE. In the case group, there were no significant differences between non‐lupus nephritis and lupus nephritis. Further, we found that the SNP rs12054797 (F = 3.228, P = 0.041, PBH = 0.342), rs2963156 (F = 3.163, P = 0.043, PBH = 0.342) might be marginally associated with disease activity.Conclusions: The study indicates that GR genetic polymorphisms may play a major role in the pathogenesis and development of SLE.